Treatment Registry
TR-0837 ActiveRecorded September 13, 2026

Compounded semaglutide

Sold by Renlo Health · Injection, vial · every compounded semaglutide record

What you actually pay

Per month

$199

Medication · Monthly$199

Added from the figures recorded below.

Price

TermPer monthCharged today
MonthlyAdvertised

Semaglutide A once-weekly compounded semaglutide injection, prescribed by a provider as part of a personalized treatment plan. $299 $199 /mo

source

Per month$199Charged today$199
Visit Renlo Health

We earn nothing from this link. Renlo Health has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 13, 2026Entry added to the register

Sourcing and terms

PharmacyVialsRx · TX · 503A
StatesAll 50 states
PrescriberAsynchronous review
Cancellation“Billed monthly. Cancel anytime, no fee.”
MembershipNone. “Everything included Medication + injection supplies Provider evaluation + ongoing care Free expedited shipping Unlimited care-team messaging No membership or consultation fees”
Consult feeNone. “No membership or consultation fees. Billed monthly. Cancel anytime, no fee.”

Recorded from renlohealth.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 13, 2026Each program page shows a struck-through figure beside the charge — “$299 $199 /mo” for semaglutide, “$399 $269 /mo” for tirzepatide. The lower number is recorded as the price because Renlo's own dose-comparison block confirms it is the standing rate rather than an introductory one: “Renlo Compounded Semaglutide Flat monthly price Price lock $199 Starting dose $199 Mid dose $199 Higher dose”. A separate site-wide banner offers “$50 off your first order with code RENLO50”, which is a first-order discount and is not recorded as the price.
  2. 2. September 13, 2026Renlo names Arora Health & Aesthetics, LLC of 300 Lenora Street, Seattle, WA as its provider group and VialsRx of 6220 Westpark Dr, Houston, TX as its partner pharmacy. Idgie Health (idgiehealth.com) names the same pharmacy at the same address and states its service availability in the same words, sentence for sentence. A reader treating the two as independent options is not getting two.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0837
Readings
1

Related records

What else Renlo Health sells

All Renlo Health programs and terms

Compounded semaglutide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 298 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Renlo Health compounded semaglutide (TR-0837). Last verified September 13, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0837

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.